Literature DB >> 9248844

Role of protein tyrosine phosphorylation in rat corneal neovascularization.

A Hayashi1, K S Popovich, H C Kim, E de Juan.   

Abstract

BACKGROUND: Recent studies have suggested that tyrosine kinase pathways that are activated by angiogenic growth factors may play a role in corneal neovascularization.
METHODS: Corneal neovascularization was induced in rat corneas by chemical cauterization. At 6, 24, 48, 96, and 168 h after chemical cauterization the rat corneas without the corneal epithelium were prepared for gel electrophoresis. Total protein profiles of the corneal samples were examined by staining gels with Coomassie brilliant blue. Tyrosine-phosphorylated proteins, three angiogenic growth factors (basic fibroblast growth factor, vascular endothelial growth factor, and platelet-derived growth factor-B chain), and three intracellular signal proteins in the tyrosine kinase pathways (phospholipase C gamma, SHC, and mitogen-activated protein kinase) in the corneal samples were examined by western blot analysis. A topical treatment of genistein eye drop (5 mg/ml) was used for inhibition of corneal neovascularization after chemical cauterization in rats.
RESULTS: In total protein profiles, three bands in the corneal samples were increased after cauterization. Overall tyrosine-phosphorylated proteins and all three angiogenic growth factors increased with progression of corneal neovascularization. The tyrosine-phosphorylated forms of three intracellular signal proteins were also increased after cauterization. Treatment with topical genistein was effective in inhibiting corneal neovascularization in rats.
CONCLUSION: Protein tyrosine phosphorylation was involved in inflammation-induced corneal neovascularization. Tyrosine kinase inhibitors may have utility as inhibitors of corneal neovascularization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9248844     DOI: 10.1007/bf00947067

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  38 in total

Review 1.  Growth factor signaling by receptor tyrosine kinases.

Authors:  J Schlessinger; A Ullrich
Journal:  Neuron       Date:  1992-09       Impact factor: 17.173

2.  Quantitation of corneal neovascularization using computerized image analysis.

Authors:  A D Proia; D B Chandler; W L Haynes; C F Smith; C Suvarnamani; F H Erkel; G K Klintworth
Journal:  Lab Invest       Date:  1988-04       Impact factor: 5.662

3.  Morphologic observations on experimental corneal vascularization in the rat.

Authors:  J S McCracken; P C Burger; G K Klintworth
Journal:  Lab Invest       Date:  1979-12       Impact factor: 5.662

Review 4.  The mitogen-activated protein kinase signal transduction pathway.

Authors:  R J Davis
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

5.  An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization. II. Studies on the effect of leukocytic elimination on corneal vascularization.

Authors:  C H Fromer; G K Klintworth
Journal:  Am J Pathol       Date:  1975-12       Impact factor: 4.307

6.  Genistein, a specific inhibitor of tyrosine-specific protein kinases.

Authors:  T Akiyama; J Ishida; S Nakagawa; H Ogawara; S Watanabe; N Itoh; M Shibuya; Y Fukami
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

7.  Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin.

Authors:  G D'Angelo; I Struman; J Martial; R I Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

8.  Use of flurbiprofen to inhibit corneal neovascularization.

Authors:  C A Cooper; M V Bergamini; I H Leopold
Journal:  Arch Ophthalmol       Date:  1980-06

Review 9.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

10.  Neovasculogenic ability of prostaglandins, growth factors, and synthetic chemoattractants.

Authors:  D BenEzra
Journal:  Am J Ophthalmol       Date:  1978-10       Impact factor: 5.258

View more
  2 in total

1.  Curcumin nanoparticles inhibit corneal neovascularization.

Authors:  Nirparaj Pradhan; Rajdeep Guha; Sushovan Chowdhury; Sudip Nandi; Aditya Konar; Sarbani Hazra
Journal:  J Mol Med (Berl)       Date:  2015-04-17       Impact factor: 4.599

2.  Comparison of the antiangiogenic activity of modified RGDRGD-endostatin to endostatin delivered by gene transfer in vivo rabbit neovascularization model.

Authors:  Hong-Yan Ge; Nan Xiao; Xiu-Li Yin; Song-Bin Fu; Jin-Ying Ge; Yan Shi; Ping Liu
Journal:  Mol Vis       Date:  2011-07-15       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.